Full-Time

Product Marketing Manager/Senior Product Marketing Manager

Confirmed live in the last 24 hours

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell receptors for diagnostics

Compensation Overview

$127.4k - $214.8k/yr

+ Equity Grant + Bonus Eligible

Mid, Senior

No H1B Sponsorship

Seattle, WA, USA

Position can be remote, but Seattle-based is preferred. Occasional travel (~15%) will be necessary to engage with customers, support business goals, and facilitate team building with a primarily remote team.

Category
Product Management
Product
Required Skills
Market Research
Data Analysis
Requirements
  • Bachelor’s degree plus 7 years of related experience, or master’s degree plus 5 years of related experience
  • Minimum of 4 years of direct experience working on a Marketing team within a highly regulated healthcare setting (e.g., pharma, biotech, hematology/oncology, and/or diagnostics)
  • Demonstrated success executing marketing strategies and tactics, including personal and non-personal promotion, display/congress, market research, and omnichannel digital channel strategy (including CRM) and related analytics within a highly regulated industry
  • Significant experience managing external vendors (including agency of record) to define and deliver scoped projects on-time and on-budget; agency-side experience may be applicable
  • Flexible and proactive approach including a strong personal drive and desire for feedback
  • Refined interpersonal skills, professional maturity, and good judgment; capable of communicating with and facilitating decisions involving a diverse group of individuals
  • Strong team player; highly effective in partnering cross-functionally and influencing without authority
  • Effective self-starter and project leader; capable of working autonomously and collaboratively to advance the broader team toward agreed-upon goals
  • Ability to clarify and overcome ambiguity; proven structured and unstructured problem-solver
  • Excellent written and oral communication and presentation skills; persuasive, engaging, and clinically credible when presenting and working with internal and external stakeholders
  • Demonstrated commitment to continuous evaluation of efforts and effectiveness
  • Engages in regular self-assessment and works to reinforce strengths and mitigate weaknesses
  • Dynamically manages priorities and workload to support functional and organizational goals
  • A passion for the healthcare field and the power of technology to improve patient lives; maintains a patient-centric attitude and approach to all work
Responsibilities
  • Contribute to, refine, and implement the promotional strategy for clonoSEQ, ensuring alignment with the overall brand and company strategy
  • Lead execution of patient marketing tactical initiatives from conception to delivery to educate patients and advocacy partners on the clinical value of clonoSEQ leveraging a data-driven approach
  • Support patient electronic medical record (EMR) platform integration efforts
  • Help develop, obtain approval of, and implement compliant marketing communications and collateral
  • Manage agency partners and other vendors on marketing campaign and collateral projects, providing direction, content feedback, and end-to-end project management
  • Develop and present product-specific field training materials, as necessary
  • Prepare for, attend, and support company activities at relevant scientific conferences
  • Identify marketing best practices and help to disseminate them throughout the team and organization; identify gaps / areas for improvement in current marketing tactics / processes and apply learnings to subsequent activities
  • Contribute to performance tracking/monitoring of marketing initiatives, including involvement in primary and secondary market research and/or data analytics
  • Accomplish business objectives by managing all projects and/or external vendors within specified budget and timeline
  • Stay abreast of the latest developments in the competitive landscape
  • Partner with clonoSEQ Marketing leadership to develop impactful annual business plans for the function, including budgets and tactical plans
  • Collaborate closely with Sales, Medical Affairs, Customer Operations, Market Access, Corporate Communications, Finance, Legal, Regulatory, and other key stakeholders to execute go-to-market strategies and multi-platform tactical plans in support of new product offerings
  • Establish, regularly evaluate, and socialize key patient audience KPIs with team, manager, and Commercial team leadership to ensure consistent alignment between ongoing work and defined business objectives
  • Partner with Sales Training to ensure optimal rollout and execution of field-based initiatives
  • Participate in field ride-a-longs to better understand promotional opportunities and challenges
  • Proactively maintains a broad understanding of the evolving market landscape, scientific advances, and industry trends
Desired Qualifications
  • MBA or scientific graduate-level degree (e.g., MPH, PharmD)
  • Degree or certification in Marketing, Communications, Public Relations, or related field
  • Hematology/oncology or immunology experience strongly preferred
  • Diagnostic product marketing experience
  • Experience in direct-to-consumer (DTC) / patient marketing and patient advocacy engagement
  • Experience developing CRM strategies from scratch
  • Field Sales experience
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies generates revenue by partnering with pharmaceutical companies, licensing their technology, and offering diagnostic services. Their goal is to advance healthcare by leveraging immune system data to develop better therapies and diagnostic tools.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Seattle, Washington

Founded

2009

Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from equity firms indicate strong market confidence and growth potential.
  • Participation in high-profile conferences suggests potential for new partnerships and collaborations.
  • Winning Workplace of the Year Award highlights strong company culture and employee satisfaction.

What critics are saying

  • Increased competition from startups like Adaptive with $20 million funding for AI models.
  • New CFO may lead to strategic shifts impacting financial stability or direction.
  • Focus on COVID-19 research may face reduced demand as pandemic attention wanes.

What makes Adaptive Biotechnologies unique

  • Pioneers in immune-driven medicine, leveraging adaptive immune system for diagnostics and treatment.
  • FDA-authorized clonoSEQ test for minimal residual disease in select blood cancers.
  • Specializes in decoding genetic information of immune cell receptors for better diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

0%
ETF Daily News
Mar 16th, 2025
Arizona State Retirement System Invests $179,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Arizona State Retirement System invests $179,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT).

GlobeNewswire
Jan 2nd, 2025
Adaptive Biotechnologies To Present At The 43Rd Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.Adaptive Biotechnologies’ management is scheduled to present on Tuesday, January 14th at 5:15 p.m. Pacific Time / 8:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.About Adaptive BiotechnologiesAdaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease

MarketBeat
Dec 10th, 2024
Jacobs Levy Equity Management Inc. Makes New $736,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Jacobs Levy Equity Management Inc. makes new $736,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT).

Adaptive Biotechnologies
Dec 3rd, 2024
Press Release Details

"We are inspired to see clonoSEQ MRD testing featured in a record-breaking number of studies at this year's ASH Annual Meeting," said Susan Bobulsky, chief commercial officer, MRD, Adaptive Biotechnologies.

ETF Daily News
Sep 29th, 2024
Canada Pension Plan Investment Board Makes New $98,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Canada Pension Plan Investment Board makes new $98,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT).